Prima BioMed Appoints Marc Voigt as CEO [Professional Services Close - Up]
(Professional Services Close - Up Via Acquire Media NewsEdge) The Board of Prima BioMed has appointed Marc Voigt as Chief Executive Officer of Prima.
According to a Company release, Voigt, Prima's Chief Business Officer and Chief Financial Officer as well as General Manager of the Company's European Operations, replaces US based Matthew Lehman who will step down from the Board but remain as an adviser to the Company to facilitate an orderly transition.
Chair of the Board of Prima Lucy Turnbull said: "The Board of Prima thanks Matt Lehman for his contribution as CEO since 2012, and before that, for his work as Chief Operating Officer since 2010. In that time, he has overseen the scaling up of Prima's operations, especially its capacity to conduct robust and comparable multi-site manufacturing of CVac, and autologous cellular therapies. With the Company's manufacturing and clinical operations now centralised in Europe, the Board considers that it is prudent and sensible for its CEO to be located there.
"Marc has done a tremendous job over the past three years as the head of our European Operations, which he knows extremely well, and has forged strong relationships within the European medical industry. As CBO and CFO Marc has an excellent knowledge of both the operational and financial aspects of the business and he has a strong investment and transactional background within the biotechnology sector. Based in Germany, he is ideally placed to assume the responsibilities as CEO and the Board looks forward to working more closely with him."
Following his appointment Voigt will join the Prima Board as an Executive Director.
((Comments on this story may be sent to firstname.lastname@example.org))
(c) 2014 ProQuest Information and Learning Company; All Rights Reserved.
[ Back To TMCnet.com's Homepage ]